{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18300", "batch_size": 260, "batch_pos": 59, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports stock movement; 'climbed' is not high-potency for threat impact.", "method": "llm_batch", "batch_id": "batch_2_14560", "batch_size": 260, "batch_pos": 42, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Relates to financial metrics, which are Neutral.", "method": "llm_batch", "batch_id": "batch_3_16328", "batch_size": 260, "batch_pos": 251, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_16436", "batch_size": 260, "batch_pos": 236, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports stock price climb after a report of funding deal, which is factual information.", "method": "llm_batch", "batch_id": "batch_5_6580", "batch_size": 260, "batch_pos": 234, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment uses a specific percentage ('2.4%') and 'a late-stage trial' which uses 'a', not Q6 minimisers, and lacks scale contrast.", "method": "llm_batch", "batch_id": "batch_6_1544", "batch_size": 260, "batch_pos": 205, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "No bare negation detected.", "method": "llm_batch", "batch_id": "batch_7_17832", "batch_size": 260, "batch_pos": 191, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Reports a potential future event/capability ('government is near a deal to fund a late-stage trial') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_16084", "batch_size": 260, "batch_pos": 41, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
